Загрузка...
Cortical Excitability Measures May Predict Clinical Response to Fampridine in Patients with Multiple Sclerosis and Gait Impairment
Background: Most multiple sclerosis (MS) patients will develop walking limitations during the disease. Sustained-release oral fampridine is the only approved drug that will improve gait in a subset of MS patients. Objectives: (1) Evaluate fampridine cortical excitability effect in MS patients with g...
Сохранить в:
| Опубликовано в: : | Brain Sci |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956091/ https://ncbi.nlm.nih.gov/pubmed/31817319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/brainsci9120357 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|